Related Experiment Video
Updated: Aug 5, 2026
09:19
Contrast Enhanced Ultrasound Imaging for Assessment of Spinal Cord Blood Flow in Experimental Spinal Cord Injury
Published on: May 7, 2015
Photobiomodulation Therapy for Traumatic Spinal Cord Injury: Current Evidence and Future Directions
Benjamin J Romanauski1, Michael W Jenkins1,2,3, Michael A Moffitt1,3
1Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA.
Neurotrauma Reports
|August 1, 2026
Summary
Photobiomodulation (PBM) therapy shows promise for treating traumatic spinal cord (SC) injury (tSCI). This non-ionizing light therapy enhances cellular function and improves functional recovery in rodent models, offering hope for tSCI treatment.
Area of Science:
- Regenerative Medicine
- Neurology
- Biophotonics
Background:
- Traumatic spinal cord injury (tSCI) results in significant motor, sensory, and autonomic function loss.
- SCI involves primary mechanical damage and secondary biochemical damage over time.
- Photobiomodulation (PBM) uses non-ionizing light to induce beneficial cellular changes without thermal damage.
Purpose of the Study:
- To review the progress of PBM therapy (PBMT) for tSCI.
- To outline the necessary steps for clinical translation of PBMT for tSCI.
Main Methods:
- Review of existing research on PBMT for tSCI.
- Analysis of PBM's proposed mechanisms in tSCI recovery.
- Identification of translational challenges and requirements.
Main Results:
- PBMT has demonstrated functional recovery in rodent models of tSCI.
- The therapy appears to work by increasing cellular energy availability and normalizing function.
- Significant progress has been made, but further research is needed.
Conclusions:
- PBMT is a promising therapeutic strategy for tSCI.
- Clinical translation requires further research on dosing, large animal models, human trials, and clinical-grade systems.
